:


Alexanian R, Dimopoulos M: The treatment of multiple myeloma. N Engl J Med 330:484, 1994

Altai M et al: A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335:91, 1996

Berenson JR et al: Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 334:488, 1996

Dimopoulos MA, Alexanian R: Waldenstrom's macroglobulinemia. Blood 83:1452, 1994

Gherardi RK et al: Overproduction of proinflammatory cytokines unbalanced by their antagonists in POEMS syndrome. Blood 87:1458, 1996

Gregory WM et al: Combination chemotherapy versus melphalan and prednisone in the treatment of multiple myeloma: An overview of published trials. J Clin Oncol 10:334, 1992

Griepp PR: Prognosis in myeloma. Mayo Clin Proc 69:895, 1994

Holland J et al: Plasmacytoma. Treatment results and conversion to myeloma. Cancer 69:1513, 1992

Kyle RA: 'Benign' monoclonal gammopathy.after 20.35 years of follow- up. Mayo Clin Proc 68:26, 1993

Kyle RA (ed.): Myeloma and related disorders, in Neoplastic Diseases of the Blood. New York, Churchill Livingstone, 1996, pp 411-705

Lust JA: Role of cytokines in the pathogenesis of monoclonal gammopathies. Mayo Clin Proc 69:691, 1994

Nordic Myeloma Study Group: Interferon-alfa2b added to melphalan- prednisone for initial and maintenance therapy in multiple myeloma. Arandomized,controlled trial. Ann InternMed 124:212, 1996

Vesole DH et al: High-dose therapy for refractory multiple myeloma: Improved prognosis with better supportive care and double transplants. Blood 85:950, 1994

: